Clinical Impact: Neurorehabilitation success is impacted by the use of a core set of outcome measures, supporting better tracking of patient progress, improved communication among clinicians and patients, and the ability to evaluate the effectiveness of interventions.
Clinical Impact: Walking speed is a valid, reliable, and sensitive measure that can be used to assess and monitor a range of populations, and be used to predict patient outcomes and guide clinical decision-making.
Clinical Impact: The brain's ability to reorganize itself through learning is the foundation for recovery after brain damage; therefore, therapy should focus on task-specific training that incorporates the principles of neural plasticity to promote functional improvement.
Clinical Impact: a comprehensive, evidence-based approach to neurorehabilitation emphasizes the importance of early intervention, interdisciplinary collaboration, patient-centered care, and functional task training, all of which are key factors in maximizing recovery and improving community participation for people who have experienced a stroke.
Clinical Impact: Integrating High Intensity Interval Training into rehabilitation programs for people with MS is a beneficial intervention when considering improvements in gait, aerobic capacity, and functional outcomes.
Clinical Impact: The clinical practice guideline on Parkinson's disease (PD) from the American Physical Therapy Association impacts clinical approaches in neurorehabilitation by emphasizing the implementation of moderate- to high-intensity aerobic exercise and resistance training to improve various motor and non-motor symptoms, functional outcomes, and quality of life for individuals with PD
Clinical Impact: A sensorimotor agility exercise program is described, to delay mobility disability in people with Parkinson's disease (PD). The program is based on a conceptual framework that identifies constraints on mobility specific to PD and incorporates movement principles from various existing exercise programs. The constraint-focused agility exercise program includes progressive levels of sensorimotor, resistance, and coordination challenges that can be customized for each patient.
Clinical Impact: Mucuna pruriens, a leguminous plant, represents a potentially valuable and accessible alternative to traditional levodopa for individuals with PD.
Clinical Impact: Early physical therapy intervention with LSVT BIG can lead to improved functional outcomes, which supports a proactive approach to neurorehabilitation by encouraging earlier referrals for physical therapy in patients with PD to address motor deficits and improve quality of life.
Clinical Impact: LSVT-BIG is a viable option for managing motor symptoms in PD patients with wearing off of medications.
Clinical Impact: LSVT is an effective speech therapy intervention for individuals with PD, improving vocal loudness and communication, and supports the clinical approach of prioritizing the LSVT method in speech therapy.
Clinical Impact: Task-specific walking training at moderate to high intensities or with virtual reality for individuals with chronic stroke, incomplete spinal cord injury, and traumatic brain injury improves walking speed and distance.
Clinical Impact: Reactive balance training is strongly supported for improved locomotor outcomes, especially when combined with other interventions.
Clinical Impact: Perturbation training alters older adults’ spontaneous walking pattern, enabling them to improve their volitional control of stability and their resistance to unpredictable and unpreventable slip-related situations.
Clinical Impact: Recent evidence supports the original recommendations from the 2016 guidelines. There is strong evidence that vestibular physical therapy provides a clear and substantial benefit to individuals with unilateral and bilateral vestibular hypofunction.
